Table 3 Analysis of laboratory tests between the CMV infection and non-CMV infection groups

 Positive

1 (4.3%)

2 (16.7%)

0.266

 Negative

22 (95.7%)

10 (83.3%)

ANCA^a

0.568

 Positive

19 (54.3%)

19 (59.4%)

 Negative

16 (45.7%)

13 (40.6%)

WBC (10^9/L)

7.82 ± 3.04

7.70 ± 3.17

0.843

Neu (10^9/L)

5.18 (3.58,6.94)

4.55 (3.36,6.9)

0.494

Eos (10^8/L)

0.2 (0.1,0.5)

0.8 (0.4,2.5)

<0.001

LY (10^9/L)

1.67 (1.21,2.35)

1.68 (1.20,2.29)

0.968

Hb (g/L)

103.06 ± 23.59

111.53 ± 23.27

0.057

PLT (10^9/L)

293 (244,364)

294 (255,330)

0.802

Albumin (g/L)

30.09 ± 5.10

34.67 ± 6.61

<0.001

Serum potassium (mmol/L)

3.78 ± 0.36

3.73 ± 0.36

0.466

Serum sodium (mmol/L)

136.41 ± 3.70

138.42 ± 2.98

0.001

ALT (U/L)

15 (10,26.75)

10 (8,16.25)

0.008

AST (U/L)

15 (11,19.25)

14.6 (11,20)

0.933

GGT (U/L)

19 (15,38)

17.0 (11.2,25.5)

0.034

ALP (U/L

62 (51.75,71.25)

64 (54.5,87.5)

0.332

IgA (g/L)

1.91 (1.21,2.29)

2.30 (1.83,2.82)

0.011

IgM (g/L)

0.52 (0.40,0.89)

0.89 (0.68,1.86)

0.002

IgG (g/L)

8.9 (6.28,11.79)

12.34 (9.40,16.20)

0.001

C3 (g/L)

0.90 (0.71,1.03)

1.02 (0.76,1.25)

0.044

C4 (g/L)

0.21 (0.16,0.24)

0.23 (0.15,0.28)

0.283

ESR (mm/h)

36.0 (17.0,53.0)

27.0 (9.5,50.0)

0.119

hsCRP (mg/L)

42.67 (17.16,74.65)

9.92 (3.68,37.71)

<0.001